The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs
Open accessAbstract
BACKGROUND: Concerns exist that women are underrepresented in trials of cardiovascular medications. OBJECTIVES: The authors sought to examine women's participation and the reported safety and efficacy by gender for pivotal cardiovascular disease (CVD) trials submitted to the U.S. Food and Drug Administration (FDA) supporting marketing applications. METHODS: On the basis of publicly available FDA reviews, the authors assessed enrollment of women in trials supporting 36 drug approvals from 2005 to 2015. Prevalence-corrected estimates for the participation of women were calculated as the percentage of women among trial participants divided by the percentage of women in the disease population (participation to prevalence ratio [PPR]), with a range between 0.8 and 1.2 reflecting similar representation of women in the trial and disease population. Sex differences in efficacy and safety were assessed. RESULTS: The proportion of women enrolled ranged from 22% to 81% (mean 46%). The calculated PPR by disease area was within or above the desirable range for atrial fibrillation (0.8 to 1.1), hypertension (0.9), and pulmonary arterial hypertension (1.4); PPR was <0.8 for heart failure (0.5 to 0.6), coronary artery disease (0.6), and acute coronary syndrome/myocardial infarction (0.6). The authors found little indication of clinically meaningful gender differences in efficacy or safety. Gender differences in efficacy or safety were described in labeling for 4 drugs. CONCLUSIONS: Women were well represented in trials of drugs for hypertension and atrial fibrillation, and overrepresented for pulmonary arterial hypertension. Representation of women fell below a PPR of 0.8 for trials in heart failure, coronary artery disease, and acute coronary syndrome. Minimal gender differences in drug efficacy and safety profiles were observed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2010 Update: A Report From the American Heart Association
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192667 · Cited by 5,700
Lee, P. Y. (2001) · JAMA · doi:10.1001/jama.286.6.708 · Cited by 849
Representation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials
Heiat, A., Gross, C. P., & Krumholz, H. M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1682 · Cited by 723
Sex-Based Differences in the Effect of Digoxin for the Treatment of Heart Failure
Rathore, S. S., Wang, Y., & Krumholz, H. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021266 · Cited by 690
Women and Ischemic Heart Disease
Shaw, L. J., Bugiardini, R., & Merz, C. N. B. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.098 · Cited by 662
Representation of Women in Randomized Clinical Trials of Cardiovascular Disease Prevention
Melloni, C., Berger, J. S., Wang, T. Y., Gunes, F., Stebbins, A., Pieper, K. S., Dolor, R. J., Douglas, P. S., Mark, D. B., & Newby, L. K. (2010) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.868307 · Cited by 455
Harris, D. J., & Douglas, P. S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430706 · Cited by 255
Sex Differences in Acute Coronary Syndrome Symptom Presentation in Young Patients
Khan, N. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.10149 · Cited by 227
Ding, E. L. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.905 · Cited by 197
Coakley, M., Fadiran, E. O., Parrish, L. J., Griffith, R. A., Weiss, E., & Carter, C. (2012) · Journal of Women's Health · doi:10.1089/jwh.2012.3733 · Cited by 186
Consideration of Sex Differences in Medicine to Improve Health Care and Patient Outcomes
Legato, M. J., Johnson, P. A., & Manson, J. E. (2016) · JAMA · doi:10.1001/jama.2016.13995 · Cited by 176
Rosano, G. M. C., Lewis, B., Agewall, S., Wassmann, S., Vitale, C., Schmidt, H., Drexel, H., Patak, A., Torp-Pedersen, C., Kjeldsen, K. P., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv161 · Cited by 175
Status of Women in Cardiovascular Clinical Trials
Kim, E. S. H., & Menon, V. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179796 · Cited by 171
Sex-Specific Chest Pain Characteristics in the Early Diagnosis of Acute Myocardial Infarction
Giménez, M. R., Reiter, M., Twerenbold, R., Reichlin, T., Wildi, K. S., Haaf, P., Wicki, K., Zellweger, C., Hoeller, R., Moehring, B., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12199 · Cited by 155
Kim, E., Carrigan, T., & Menon, V. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.025 · Cited by 139
Age-Specific Gender Differences in In-Hospital Mortality by Type of Acute Myocardial Infarction
Zhang, Z., Fang, J., Gillespie, C., Wang, G., Hong, Y., & Yoon, P. W. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.12.001 · Cited by 137
Adverse effects in women: implications for drug development and regulatory policies
Parekh, A., Fadiran, E. O., Uhl, K., & Throckmorton, D. C. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.29 · Cited by 114
Poon, R., Khanijow, K., Umarjee, S., Fadiran, E. O., Yu, M., Zhang, L., & Parekh, A. (2013) · Journal of Women s Health · doi:10.1089/jwh.2012.3753 · Cited by 102
Halpern, S. D., Karlawish, J. H., Casarett, D., Berlin, J. A., Townsend, R. R., & Asch, D. A. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00507-6 · Cited by 89
Gender Bias in Studies for Food and Drug Administration Premarket Approval of Cardiovascular Devices
Dhruva, S. S., Bero, L. A., & Redberg, R. F. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.958215 · Cited by 87
Singh, J. A., Lu, X., Ibrahim, S. A., et al. (2014) · BMC Medicine · doi:10.1186/s12916-014-0190-6 · Cited by 83
Eshera, N., Itana, H., Zhang, L., Soon, G., & Fadiran, E. O. (2015) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000177 · Cited by 82
Tsang, W., Alter, D. A., Wijeysundera, H. C., Zhang, T., & Ko, D. T. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1768-8 · Cited by 65
Comorbidities in Heart Failure: Are There Gender Differences?
Hopper, I., Kotecha, D., Chin, K. L., Mentz, R. J., & von Lueder, T. G. (2016) · Current Heart Failure Reports · doi:10.1007/s11897-016-0280-1 · Cited by 59
Fadiran, E. O., & Zhang, L. (2014) · Springer eBooks · doi:10.1007/978-3-319-12406-3_2 · Cited by 44
Who will participate in acute stroke trials?
Kasner, S. E., Giudice, A. D., Rosenberg, S. L., Sheen, M., Luciano, J. M., Cucchiara, B. L., Messe, S. R., Sansing, L. H., & Baren, J. M. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a55fbe · Cited by 44
Sex Differences in the Pathophysiology, Treatment, and Outcomes in IHD
Sanghavi, M., & Gulati, M. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0511-z · Cited by 41
Kramer, D. B., Mallis, E., Zuckerman, B. D., Zimmerman, B., & Maisel, W. H. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181ca8105 · Cited by 38
Kragholm, K. H., Halim, S. A., Yang, Q., Schulte, P. J., Hochman, J. S., Melloni, C., Mahaffey, K. W., Moliterno, D. J., Harrington, R. A., White, H. D., et al. (2015) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.114.001615 · Cited by 37
Who refuses enrollment in cardiac clinical trials?
Biswas, M. S., Newby, L. K., Bastian, L. A., Peterson, E. D., & Sugarman, J. (2007) · Clinical Trials · doi:10.1177/1740774507079434 · Cited by 35
Refusal to participate in heart failure studies: do age and gender matter?
Harrison, J. M., Jung, M., Lennie, T. A., Moser, D. K., Smith, D. G., Dunbar, S. B., Ronis, D. L., Koelling, T. M., Giordani, B., Riley, P. L., et al. (2016) · Journal of Clinical Nursing · doi:10.1111/jocn.13135 · Cited by 30
Cited by
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
Laufs, U., Banach, M., Mancini, G. B. J., Gaudet, D., Bloedon, L. T., Sterling, L. R., Kelly, S., & Stroes, E. S. G. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011662 · Cited by 432
Women’s Participation in Cardiovascular Clinical Trials From 2010 to 2017
Jin, X., Chandramouli, C., Allocco, B., Gong, E., Lam, C. S. P., & Yan, L. L. (2020) · Circulation · doi:10.1161/circulationaha.119.043594 · Cited by 403
Sex as a Biological Variable: A 5-Year Progress Report and Call to Action
Arnegard, M. E., Whitten, L. A., Hunter, C., & Clayton, J. A. (2020) · Journal of Women's Health · doi:10.1089/jwh.2019.8247 · Cited by 354
Cardiovascular Disease and the Female Disadvantage
Woodward, M. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16071165 · Cited by 329
A 10-year follow-up study of sex inclusion in the biological sciences
Woitowich, N. C., Beery, A., & Woodruff, T. (2020) · eLife · doi:10.7554/elife.56344 · Cited by 320
Metadata
- Authors
- Scott, P. E., Unger, E. F., Jenkins, M. R., Southworth, M. R., McDowell, T.-Y., Geller, R. J., Elahi, M., Temple, R. J., & Woodcock, J.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 71
- Issue
- 18
- Pages
- 1960-1969
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2800815486
- Cited by
- 366
- References
- 31
- FWCI
- 29.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.